Congenital heart disease (CHD) is the most common neonatal congenital malformation. The variety and severity of clinical presentation depend on the cardiac structures involved and their functional impact.
Introduction
Congenital heart disease (CHD) is the most common congenital neonatal malformation with a reported prevalence between 4 and 10 per 1000 live births. [1] [2] [3] [4] The variety of cardiac defects is very wide because of the several pathologic combinations of different heart structures involved (atrias, ventricles, walls, large arteries, veins, valves).
To date, there is no unequivocal classification of congenital heart defects, since they can be categorized according to pathogenetic (pathogenetic classification), anatomic (anatomic classification) or functional criteria (clinical approach). This last one is the most used because the functional aspect of heart disease determines the therapeutic management at birth.
Clinical aspects of congenital heart defects vary from mild to critical. Severe CHD are lifethreatening and require immediate intervention. These forms, such as those requiring cardiac catheterization or surgery within the first year of life, represent 25% of all congenital heart disease. 2 They are often ductus arteriosus (DA) dependent cardiopathies, because DA is the only way to ensure systemic and/or pulmonary perfusion.
Univentricular cardiopathies are the most complex among the severe forms. They are characterized by complete mixing, in atrias or ventricles, of systemic and pulmonary venous return (e.g. tricuspid atresia, hypoplastic left heart syndrome, heterotaxic conditions with asplenia or polysplenia). In these cases, the ventricular output is divided into two parallel circuits and due to complete blood mixing, oxygen saturations in aorta and in pulmonary artery are the same. Blood volume in each system depends on the resistances of the two circuits and on anatomical obstruction to pulmonary or systemic outflow.
Prognosis of newborns suffering from congenital heart disease, however, does not depend exclusively on the heart defect, but also on the presence of comorbidity (respiratory, gastrointestinal, renal, cerebral). After initial stabilization, these patients require a multidisciplinary approach, including proper nutritional management. Management of dysphagia, gastroesophageal reflux, intestinal malrotations combined with continuous enteral nutrition (both in pre-and post-operative period) and a tailored caloric intake can lead the newborn to surgery in good clinical conditions, reducing pre-and post-operative morbidity and mortality.
Nutritional requirements in cardiopathic newborn
Newborns affected by severe CHD may require an increased energy intake because, in addition to the physiological growth process, critical illnesses can lead to a risen protein catabolism and turnover. Failure to thrive of cardiopathic infants has been associated to long-term cognitive delay, including attention deficit disorders, aggressive behaviour and poor social and emotional development. [5] [6] [7] Furthermore, malnutrition has shown to be associated with unfavorable clinical outcomes, both in pediatric and adult population. In fact, it has been associated with delayed wound healing, myocardial dysfunction, vascular endothelial damage, reduced muscular function and increased risk of post-operative infections (in particular pneumonia). 8, 9 Mehrizi and Drash, already in 1962, showed that weight loss (prevalence of 55%) was associated to an equally significant statural deficit (prevalence of 52%) in cardiopathic newborns and highlighted the need of univocal recommendations for these patients. To date, there are still no guidelines on this topic. 10, 11 It is well established that these patients, mainly those with univentricular cardiopathies, have high incidence of extrauterine growth retardation and a poor height-weight growth, despite having adequate weight for gestational age at birth. 12 Weight deficit is the first and most severely involved, followed by a delay in statural and cranial circumference growth.
Although resting energy expenditure (REE) is normal or only moderately increased, overall energy expenditure -especially in critical illnesses -is significantly increased. Many factors are involved in this process: an increased metabolic demand due to heart failure (often associated with respiratory failure and therefore inadequate tissue oxygenation), surgical stress, malabsorption and suboptimal caloric intake. Furthermore, about 25% of cardiac newborns are small for gestational age, because of several reasons, such as genetic disorders. Associated genetic conditions such as Down syndrome, DiGeorge syndrome, Turner syndrome and trisomy 13 and 18, in fact, may influence energy intake, gastrointestinal absorption, expenditure and growth expectations. 13 It is also important to consider that a low weight at the time of surgery affects an increased mortality in CHD children, and postoperative weight loss is a prognostic unfavorable index related to late mortality. 14, 15 There are several aspects and potential contraindications regarding nutrition of infants with CHD (Table 1) .
Infants affected by CHD are often critical patients because they are also surgical patients. This leads to increased protein catabolism and turnover. The goals of nutrition in critically ill patients are to provide an adequate protein intake to facilitate wound healing, modulate the inflammatory response and preserve muscle mass. However, in infants with CHD the prevalence of malnutrition and chronic protein deficiency is documented in nearly half of the cases, respectively with only 68% and 40% of adequate energy and protein requirements at one week of life. 16 Currently, there are no clinical indicators or biochemical markers to define the REE and the optimal energy supplies to be provided in each case. The lastest American Society for Parenteral and Enteral Nutrition clinical guidelines for nutrition in the critically ill child set the protein requirement at 2-3 g/kg/d for infants 0 to 2 years of age. Preterm neonates have a greater protein requirement of 3.5-4 g/kg/d to promote growth during this critical period. 17 More details on parental and enteral nutrition have been described in the Appendix.
Necrotizing enterocolitis in cardiac newborn
Concerns regarding the initiation of feeding in patients on prostaglandins, with low cardiac output, cyanosis or shunts are arisen by many clinicians for the risk of necrotizing enterocolitis (NEC) [18] [19] [20] The incidence of NEC in neonates with CHD ranges from 1.62% to 7.8% and it may be due to an abnormal vascular flow in mesenteric vessels because of the underlying cardiac disease. [20] [21] [22] In particular, patients with cyanogenic or single ventricle cardiomyopathy are at higher risk for NEC.
In preterm population, NEC typically develops at 2 to 4 weeks of age, while term infants with CHD are most likely to develop NEC in the first 7 days of life. However, disease localization to the terminal small bowel does not seem to differ between the two groups. 23 It should be stressed that delay in oral feeding may increase the severity of NEC and can lead to intestinal mucosal atrophy with loss of barrier function. The postponed initiation of feeding may also worsen alteration of saprophytic flora (as much as during antibiotic therapy). On the other hand, early start of minimal enteral feeding (MEF), improves intestinal mucosa development and maturation of its associated immune system. 24 Lyvonne and colleagues analysed the pre-and post-operative nutritional strategies in 59 cardiac children of pediatric and neonatal intensive care units from 18 European countries. They showed that in many units, pre-surgical enteral feeding is not routinely started. In one-third of the units, clinicians are uncomfortable in feeding patients while on prostaglandin infusion and there is a high concern about potential complications (first of all NEC), especially when nutrition is carried through an umbilical arterial catheter.
An optimal timing for beginning parenteral nutrition is not defined: it ranges from less than three days to a week. Moreover, regarding the post-operative period, there is no uniformity about contraindications to enteral feeding during therapy with vasoactive drugs, about the appropriate caloric target to provide and regarding indications to stop enteral nutrition (for example, for procedures such as cardiac catheterization or chest tubes or central lines placement). 25 It is therefore evident how this lack of uniformity warrants further research in the next future.
Breast milk nutrition
Breast milk is considered the ideal nutrition for all newborns. The World Health Organization recommends exclusive breastfeeding up to 6 months of life because of proven nutritional, immunological and interpersonal (mother-child) benefits. Several studies showed the beneficial effects of breast milk in premature babies especially in reducing the incidence of NEC, while there is lack of evidence about the benefits of exclusive breastfeeding in newborns with CHD. 26 Furthermore, caloric intake of mother's milk may not be enough to support the growth of infants affected by CHD. Some studies, in fact, documented the use of formulas fortified with glucolipidic or glucidic components in this group of patients. 27 An observational study of 122 newborns undergoing surgery for univentricular and biventricular cardiopathy, however, showed that postoperative growth and hospitalization are not influenced by the type of milk administered. 28 It is important to consider that the period following birth is extremely stressful for mothers and families. This can negatively influence mothers' ability to provide the baby her own milk. Of note, a recent study from the Children's Hospital in Philadelphia showed that breastfeeding of CHD infants can be successful if mothers receive prenatal lactation consultation focusing on the provision of human milk. 29 Given the well-known nutritional and immunological role of human milk, donor milk is recommended as an alternative when mother production is not enough.
In conclusion, although there are no studies specifically focused on infants affected by congenital heart disease, it seems that human milk is the first choice also for these patients.
Post-discharge nutrition and growth
Nutritional issues of cardiopathic infants continue after hospital discharge. Difficulties in oral feeding, in fact, are frequent in these patients and can even get worse after cardiac surgery. Several studies documented a high rate of failure to thrive in infants with CHD after discharge, both in severe and milder forms. 30, 31 Although surgical repair of heart defects in the neonatal period usually results in weight gain within a few months, longitudinal growth and head circumference often experience delay for a year or more. Different causes contribute to this, such as persistent heart failure, aortic arch surgery, neurological damage, any associated genetic abnormalities, vocal cords injury by prolonged intubation, use of trans-oesophageal echocardiography, malabsorption, dysphagia, oral feeding aversion and gastroesophageal reflux. For these reasons, 44.6% of infants with CHD required feeding tubes at discharge because of a delay in full oral feeding attainment. 32 Despite a more favourable feeding outcome in those with early beginning of oral feed, a significant percentage requires gavage feeding at discharge and about 20% of patients with hypoplastic left heart syndrome receive a percutaneous endoscopic gastrostomy. 33 The most effective method to ensure adequate nutritional intake is through continuous enteral feeding in 24 hours. At home it may be easier for parents to provide nutrition in 18-20 hours. The disadvantage of this type of tube feeding consists in poor oralmotor functions and in delayed progression of adequate oral intake. Several approaches can be used to combine oral feeding with tube feeding to provide adequate caloric intake and maintain oral-motor feeding skills. One approach is to allow the infant to feed by nipple for a restricted period of time (generally 10-20 minutes) and then administer the remaining milk volume via the nasogastric tube. Another commonly used method is to encourage ad libitum oral feeding of breast milk (or fortified formula) during the day (8 to 12 hours), then provide the balance of the daily nutritional needs by continuous feeding during the night hours. 34 It is important to perform close monitoring of growth and nutrition of infants affected by CHD both during hospitalization and after hospital discharge, especially in the first year of life, to promote adequate neurodevelopment. Some centres have established home monitoring programs with the aim of nutritional surveillance and management after discharge. 35 Families are discharged home with weighing scale and trained to record daily weight. Critical situations suggestive for inadequate nutritional intake require a rapid clinical evaluation and are illustrated in Table 2 and indicated as red flags.
Conclusions
Infants affected by CHD have a greater risk of malnutrition and growth deficit, with negative long-term neurological outcomes. Currently, there are lack of evidence regarding nutritional approach in these patients and no guidelines available. However, literature highlights the importance of nutrition in the management of infants affected by CHD. 
